SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-21-001542
Filing Date
2021-02-11
Accepted
2021-02-11 17:22:29
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3/A azrxs3am1_feb2021.htm S-3/A 899400
2 OPINION ON LEGALITY ex5-1.htm EX-5 11365
3 IMAGE azrxs3_feb12021000.jpg GRAPHIC 2795
4 IMAGE azrxs3_feb12021001.jpg GRAPHIC 3926
5 IMAGE ls.jpg GRAPHIC 2855
  Complete submission text file 0001654954-21-001542.txt   925492
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-252623 | Film No.: 21621038
SIC: 2834 Pharmaceutical Preparations